Your browser doesn't support javascript.
loading
Reliability of the triple-timed up-and-go test.
Sanders, Donald B; Guptill, Jeffrey T; Ales, Kathy L; Hobson-Webb, Lisa D; Jacobus, David P; Mahmood, Riaz; Massey, Janice M; Pittman, Melissa M; Prather, Kristi; Raja, Shruti M; Yow, Eric; Juel, Vern C.
  • Sanders DB; Neuromuscular Section, Department of Neurology, Duke University Medical Center, Box 3403, Durham, North Carolina, 27710, USA.
  • Guptill JT; Neuromuscular Section, Department of Neurology, Duke University Medical Center, Box 3403, Durham, North Carolina, 27710, USA.
  • Ales KL; Jacobus Pharmaceutical Company, Princeton, New Jersey, USA.
  • Hobson-Webb LD; Neuromuscular Section, Department of Neurology, Duke University Medical Center, Box 3403, Durham, North Carolina, 27710, USA.
  • Jacobus DP; Jacobus Pharmaceutical Company, Princeton, New Jersey, USA.
  • Mahmood R; Campbell University School of Osteopathic Medicine, Lillington, North Carolina, USA.
  • Massey JM; Neuromuscular Section, Department of Neurology, Duke University Medical Center, Box 3403, Durham, North Carolina, 27710, USA.
  • Pittman MM; Neuromuscular Section, Department of Neurology, Duke University Medical Center, Box 3403, Durham, North Carolina, 27710, USA.
  • Prather K; Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Raja SM; Neuromuscular Section, Department of Neurology, Duke University Medical Center, Box 3403, Durham, North Carolina, 27710, USA.
  • Yow E; Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Juel VC; Neuromuscular Section, Department of Neurology, Duke University Medical Center, Box 3403, Durham, North Carolina, 27710, USA.
Muscle Nerve ; 57(1): 136-139, 2018 Jan.
Article en En | MEDLINE | ID: mdl-28545168
ABSTRACT

INTRODUCTION:

We report the reliability of a new measure, the triple-timed up-and-go (3TUG) test, for assessing clinical function in patients with Lambert-Eaton myasthenia (LEM).

METHODS:

Intrarater reproducibility and interrater agreement of the 3TUG test were assessed in 25 control participants, 24 patients with non-LEM neuromuscular disease, and 12 patients with LEM. The coverage probability (CP) method was the primary measure of reproducibility and agreement. The a priori acceptable range was < 20% difference in 3TUG test times and a CP ≥0.90 confirmed agreement.

RESULTS:

CP values > 0.90 for intrarater and interrater tests confirmed acceptable reproducibility and agreement for all groups.

DISCUSSION:

The 3TUG test is a quick, noninvasive, and reproducible measure that is easy to perform, measures clinically important weakness in LEM patients, and requires little training. Additional evaluation in a larger number of LEM patients is in progress to validate the 3TUG test as a clinical measure in LEM. Muscle Nerve 57 136-139, 2017.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome Miasténico de Lambert-Eaton Tipo de estudio: Diagnostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome Miasténico de Lambert-Eaton Tipo de estudio: Diagnostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article